173 related articles for article (PubMed ID: 35781038)
21. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
22. Determinants of survival following pelvic exenteration for primary rectal cancer.
Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
[TBL] [Abstract][Full Text] [Related]
23. Pelvic exenteration for rectal cancer: a systematic review.
Yang TX; Morris DL; Chua TC
Dis Colon Rectum; 2013 Apr; 56(4):519-31. PubMed ID: 23478621
[TBL] [Abstract][Full Text] [Related]
24. Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancer.
Däster S; Shin JS; Loizides S; Steffens D; Koh CE; Solomon MJ
Eur J Surg Oncol; 2021 Aug; 47(8):2100-2107. PubMed ID: 33895021
[TBL] [Abstract][Full Text] [Related]
25. Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer.
Fahy MR; Hayes C; Kelly ME; Winter DC
Eur J Surg Oncol; 2022 Nov; 48(11):2284-2291. PubMed ID: 35031157
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
27. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
[TBL] [Abstract][Full Text] [Related]
28. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
30. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
31. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
32. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
33. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer.
Brown WE; Koh CE; Badgery-Parker T; Solomon MJ
Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910
[TBL] [Abstract][Full Text] [Related]
34. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
[TBL] [Abstract][Full Text] [Related]
35. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
36. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.
Sasikumar A; Bhan C; Jenkins JT; Antoniou A; Murphy J
Dis Colon Rectum; 2017 Mar; 60(3):346-352. PubMed ID: 28177998
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of extended total mesorectal excision in patients with locally advanced rectal cancer.
Saravanabavan S; Kazi M; Murugan J; Vispute T; Vijayakumaran P; Desouza A; Saklani A
Colorectal Dis; 2023 Jul; 25(7):1423-1432. PubMed ID: 37246309
[TBL] [Abstract][Full Text] [Related]
38. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
[TBL] [Abstract][Full Text] [Related]
39. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
40. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]